Navigation Links
Influenza: Insights into cell specificity of human vs. avian viruses
Date:10/9/2007

Rotterdam, The Netherlands Researchers have identified which sites and cell types within the respiratory tract are targeted by human versus avian influenza viruses, providing valuable insights into the pathogenesis of these divergent diseases. The report by van Riel et al, Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals, appears in the October issue of The American Journal of Pathology and is accompanied by a commentary and highlighted on the cover.

Differences in cellular expression of target molecules correspond to host specificity of influenza viruses. They also define which organs or tissues are infected within the host. For example, highly pathogenic H5N1 avian influenza virus targets cells deep within the lower respiratory tract whereas human influenza virus is thought to target cells of the upper respiratory tract, including the trachea.

To better elucidate the differences between low and highly pathogenic avian influenza virus versus human influenza virus, researchers led by Dr. Thijs Kuiken of Erasmus MC, Rotterdam, The Netherlands, used a technique called virus histochemistry. This method examines the attachment pattern of influenza virus to isolated respiratory tissues, thus identifying the cells targeted by the virus.

When human viruses were tested, both attached strongly to the trachea and bronchi, but virus binding to the bronchioles and alveoli (deeper within the lung) was less abundant in comparison. In contrast, viral attachment of avian viruses was rare in the trachea but more abundant in the bronchioles and alveoli. Further, the cellular targets in the alveoli also differed: human virus preferred type I pneumocytes whereas avian virus bound type II pneumocytes and alveolar macrophages. Interestingly, low and highly pathogenic avian influenza viruses attached to the same cell types, demonstrating that factors other than binding ability must contribute to the pathogenicity.

These data are consistent with the differences in human disease presentation, with human influenza causing tracheobronchitis and highly pathogenic avian influenza causing severe pneumonia. But which animal models are the best for studying the disease in humans" To answer this question, the authors next assessed the pattern of virus attachment in animal models used for influenza studies. Of several mammals tested, ferrets, cats, and pigs most closely resembled the human patterns of virus attachment for avian influenza viruses, thus demonstrating their usefulness as models of infection and disease.

These studies improve our understanding of the pathogenesis of human respiratory tract disease from both human and avian influenza A virus infection, state the authors. Combined with the results obtained with different animal models, they may lead to a better understanding of the factors that are critical for virus binding and infection, enabling the future development and testing of feasible control strategies.


'/>"/>

Contact: Audra Cox
acox@asip.org
301-634-7409
American Journal of Pathology
Source:Eurekalert

Related medicine news :

1. Avian Influenza: Government to set up expert committee
2. New insights into herbal supplements
3. Wrinkle reduction cream has offered insights into working of nervous system
4. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
5. Reindeer Provide Valuable Insights Into Sleep Disorders
6. New Insights into Antimalarial Drug Resistance
7. Insights Into Lead Pollution
8. Insights into Osteosarcoma in Cats and Dogs may Improve Palliative Care
9. Neural Basis of Anxiety: Newer Insights
10. New Insights into Chronic Inflammation and Atherosclerosis
11. Rare Womens Lung Disease May Yield Insights Into Common Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... further expand its existing adherence automation lines. The ATP® Mini and InspectRx® ... technology of TCG’s standard products, but at a size and price point that ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... services since 2014, top travel insurance solution company VisitorsCoverage Inc. has launched TMQuotes, ... all major international travel insurance products online, under their own brand. The online ...
(Date:7/20/2017)... ... July 19, 2017 , ... A local ... and increased funds raised to support fine arts programs in Chester County’s Elementary ... in Freed-Hardeman University’s Loyd Auditorium. , More than 850 people attended the ...
(Date:7/20/2017)... ... 2017 , ... Med Tech Solutions (MTS), a leading health care cloud computing ... Constellation Inc., a move that will help the company better serve its clients and ... acquisition is expected to help MTS expand its presence in the Midwest ...
(Date:7/20/2017)... , ... July 19, 2017 , ... A July 5th ... successful weight loss surgery patients who had received a body contouring procedure reported experiencing ... beauty clinic Beverly Hills Physicians (BHP), which provides both types of procedures, notes that ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... 14, 2017 Endo International plc (NASDAQ: ENDP ... 8, 2017.  Members of its senior management team will host a ... 8:30 a.m. ET. The dial-in number to access ... (678) 509-7598, and the passcode is 45397076. Please dial in 10 ... A replay of the call will be available ...
(Date:7/13/2017)... 13, 2017  Centurion Medical Products, a leader in medical product ... fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part ... alleviate patient pain while preventing unneeded emergency department admission due to ...
(Date:7/13/2017)... , July 13, 2017  New York City-based market research ... markets should be aware of.  From new products to new ... detailed in a recently completed study, Potential Pipeline Disruptors ... 1.  Age-Driven Growth - True ... been aware of the impact the growing population and, to ...
Breaking Medicine Technology: